glutathione clinical trial news 2025 Nucleic acid drugs: recent progress and future perspectives HuidaGene Selected for Presidential Symposium
HuidaGene Selected for Presidential Symposium at ASGCT 2025 Annual Meeting, Showcasing 13 Abstracts Demonstrating Breakthroughs in Gene Therapy Press release HUIDAGENE A phase I II study of the safety and efficacy of telaglenastat (CB 839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non small cell lung cancer ESMO Open OCT DACH 2025: Geopolitics, trial equity and technology take centre stage Clinical Trials Arena The Annual Clinical Trials Roundup, 2025 Edition Citeline North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




